Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$27,000.00

Exploring the triggers of ectosome formation in Parkinson's disease

EF 2024-25

Résumé
Parkinson disease is a neurodegenerative movement disorder affecting 1 in every 500 Canadians. It is well known that this disease involves transfer of a protein called alpha-synuclein between cells. However, the mechanisms of this protein transmission are poorly understood. Inflammation is another hallmark of Parkinson disease. Emerging evidence points towards lipid dysregulation as another prominent feature in Parkinson disease. We recently discovered that lipid alterations in Parkinson disease neurons promote the shedding of a specific type of extracellular vesicle called ectosomes. These ectosomes are loaded with pathogenic alpha-synuclein spreading Parkinson disease pathology to neighbouring neurons. Whether inflammation and/or pathological alpha-synuclein can stimulate ectosome formation has not been tested. This project will utilize live-cell imaging and neurons generated from Parkinson disease patient induced pluripotent stem cells to investigate inflammation and pathological alpha-synuclein as potential triggers of ectosome formation. We will test if different pathological forms of alpha-synuclein, including mutant and misfolded forms, enhance ectosome release. We will also test if inflammatory cytokines stimulate ectosome release. Parkinson disease is a devastating neurodegenerative disorder, and how ectosomes are regulated in this disease is poorly understood. This project will help elucidate the pathways involved in ectosome formation during Parkinson disease. Establishing a fundamental characterization of this process may reveal new targets for therapy to limit propagation of Parkinson disease pathology.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530343
Name
Chik Kennedi
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the triggers of ectosome formation in Parkinson's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alpha-Synuclein; Cytokines; Ectosome; Extracellular Vesicle; Lipid; Live-Cell Imaging; Parkinson'S Disease; Protein-Transmission
Abstract
Parkinson disease is a neurodegenerative movement disorder affecting 1 in every 500 Canadians. It is well known that this disease involves transfer of a protein called alpha-synuclein between cells. However, the mechanisms of this protein transmission are poorly understood. Inflammation is another hallmark of Parkinson disease. Emerging evidence points towards lipid dysregulation as another prominent feature in Parkinson disease. We recently discovered that lipid alterations in Parkinson disease neurons promote the shedding of a specific type of extracellular vesicle called ectosomes. These ectosomes are loaded with pathogenic alpha-synuclein spreading Parkinson disease pathology to neighbouring neurons. Whether inflammation and/or pathological alpha-synuclein can stimulate ectosome formation has not been tested. This project will utilize live-cell imaging and neurons generated from Parkinson disease patient induced pluripotent stem cells to investigate inflammation and pathological alpha-synuclein as potential triggers of ectosome formation. We will test if different pathological forms of alpha-synuclein, including mutant and misfolded forms, enhance ectosome release. We will also test if inflammatory cytokines stimulate ectosome release. Parkinson disease is a devastating neurodegenerative disorder, and how ectosomes are regulated in this disease is poorly understood. This project will help elucidate the pathways involved in ectosome formation during Parkinson disease. Establishing a fundamental characterization of this process may reveal new targets for therapy to limit propagation of Parkinson disease pathology.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chik, Kennedi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~